Yasmine Hassan, Director of Global Oncology Policy, Advocacy, and Health Equity at AstraZeneca, shared a post on LinkedIn:
“We were proud to sponsor a fireside chat at the World Hepatitis Summit in Bangkok on HCC Surveillance: Earlier Detection, Improved Outcomes and MDT.
It was great to hear from our panel on the important of ensuring patients are able to access multidisciplinary care following identification – key principle of the HCC Patient Charter.
A big thank you to the panel Achim Kautz, Roberta Sarno, PhD and Dr Niti Haetanurak for such a thoughtful and engaging conversation, to Dee Lee for expert moderation, and to the The World Hepatitis Alliance for organizing the Summit.”
Other articles featuring Yasmine Hassan on OncoDaily.